NorthWest Biotherapeutics Inc (NWBO)

[vator]

Like most of these types of treatments tough to observe if tumor expansion is due to disease of T- Cell infiltration. Measurements from a chemo background are not holding up. Probably discussions with FDA over screening halt on how to handle this. ARGS at the same time was allowed to restart and finish their trial when NWBO screening halt was lifted.

Just do not thing the old measurements of PFS are going to be as worthwhile measuring efficacy. If the company said anything to this effect it would have added bias to the trial. Just need to wait for the final data.